RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy / Actinium-225, ACTION-1 Trial, BMS, ...
Visara, Inc., a Rockville, Maryland-based ophthalmology company and majority-owned subsidiary of NovaBridge Biosciences (Nasdaq: NBP), announced on ...
SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All ...
Visara secures exclusive worldwide rights, excluding Greater China, from Wuhan Hiteck Biological Pharma to develop and commercialize ...
Bristol Myers Squibb ( NYSE: BMY) today announced positive topline results from the planned interim analysis of the ACTION-1 trial (NCT05477576) conducted by RayzeBio, Inc., a Bristol Myers Squibb ...
The investigational radiopharmaceutical therapy RYZ101 (225Ac-DOTATATE) produced a statistically significant and clinically ...
Long-term use of anabolic-androgenic steroids (AAS) has serious consequences for the heart, according to a new study that has ...
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des ...
Below are the CEO and CFO prepared remarks from Johnson & Johnson's third-quarter 2026 earnings call. For the complete transcript, financial results, supplemental materials and additional information, ...
J&J Q3 2026 earnings: profit fell 96%, mainly on a $5.5 billion legal charge tied to its talc offer. How the offer compares ...
The Friends of the Otto Bruyns Public Library of Northfield is having a Book & Bake Sale 10 a.m. to 4 p.m. Friday, Oct. 16, and 10 a.m. to 1 p.m. Saturday, Oct. 17, at the library, 241 Mill Road. Get ...
A new approach promises rapid relief—but is faster really better? Here’s what experts say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results